Fig. 4
From: CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia
YKL-40 and GFAP in distinct FTD clinical syndromes and molecular subtypes. a CSF YKL-40 in FTD clinical groups. b CSF YKL-40 in FTLD-TAU, FTLD-TDP without ALS, and FTLD-TDP with ALS. c CSF GFAP in FTD clinical groups. d CSF GFAP in FTLD-TAU, FTLD-TDP without ALS, and FTLD-TDP with ALS. Horizontal lines represent medians. GFAP values are expressed in logarithmic scale. Only statistically significant differences are displayed (Kruskal-Wallis test followed by Dunn-Bonferroni post hoc test)